TALEN

TALEN1-lnc.veal2

ID

ZDB-TALEN-221102-3

Name

TALEN1-lnc.veal2

Previous Names

None

Target

Target Sequence 1

5' - CATTAGGAAACCCCA - 3'

Target Sequence 2

5' - AAACCCGTCAATGTG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

unable to verify target sequence 2, AKA veal2 5’ Right TALE1, AAACCCGTCAATGTG

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
gib005	lnc.veal2

Expression

Gene expression in Wild Types + TALEN1-lnc.veal2

No data available

Phenotype

Phenotype resulting from TALEN1-lnc.veal2

No data available

Phenotype of all Fish created by or utilizing TALEN1-lnc.veal2

Phenotype	Fish	Conditions	Figures
vasculature cytosol decreased amount, abnormal	lnc.veal2^gib005/+	standard conditions	Fig. 4 from Sehgal et al., 2021
vasculature membrane docking increased frequency, abnormal	lnc.veal2^gib005/+	standard conditions	Fig. 4 from Sehgal et al., 2021
cranial vasculature increased permeability, abnormal	lnc.veal2^gib005/+	standard conditions	Fig. 4 from Sehgal et al., 2021
cranium blood DsRed expression increased amount, abnormal	lnc.veal2^gib005/+; sd2Tg/sd2Tg; y1Tg/y1Tg	standard conditions	Fig. 2 from Sehgal et al., 2021
cranial vasculature increased permeability, abnormal	lnc.veal2^gib005/+; sd2Tg/sd2Tg; y1Tg/y1Tg	standard conditions	Fig. 2 , Fig. 3 from Sehgal et al., 2021
protein kinase C binding decreased process quality, abnormal	lnc.veal2^gib005/+; sd2Tg/sd2Tg; y1Tg/y1Tg	standard conditions	Fig. 3 from Sehgal et al., 2021
cranial vasculature permeability, ameliorated	lnc.veal2^gib005/+; sd2Tg/sd2Tg; y1Tg/y1Tg	chemical treatment by environment: EC 2.7.11.13 (protein kinase C) inhibitor	Fig. 3 from Sehgal et al., 2021

Citations